申请人:AJINOMOTO CO., INC.
公开号:US20150011511A1
公开(公告)日:2015-01-08
Compounds represented by formula (I):
wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes.
化合物的化学式为(I):其中每个符号的定义如描述中所述,并且其药用盐是有用的高血糖抑制剂,具有丝氨酸蛋白酶抑制作用,并且作为糖尿病的预防或治疗药物。